CA2431545A1 - Antagonistes du recepteur d'acide amine excitateur - Google Patents
Antagonistes du recepteur d'acide amine excitateur Download PDFInfo
- Publication number
- CA2431545A1 CA2431545A1 CA002431545A CA2431545A CA2431545A1 CA 2431545 A1 CA2431545 A1 CA 2431545A1 CA 002431545 A CA002431545 A CA 002431545A CA 2431545 A CA2431545 A CA 2431545A CA 2431545 A1 CA2431545 A1 CA 2431545A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- pharmaceutically acceptable
- alkyl
- acceptable salt
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne des nouveaux sels acceptables au plan pharmaceutique de composés de formule I et de formule Ia, des procédés d'utilisation desdits sels, ainsi que des procédés de fabrication de composés de formule I et de formule Ia, ou des sels pharmaceutiquement acceptables de ceux-ci. Lesdits composés de formule I et de formule Ia sont utiles pour le traitement de troubles neurologiques, notamment de la migraine.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 | |
| US60/260,014 | 2001-01-05 | ||
| PCT/US2001/044715 WO2002053561A1 (fr) | 2001-01-05 | 2001-12-20 | Antagonistes du recepteur d'acide amine excitateur |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2431545A1 true CA2431545A1 (fr) | 2002-07-11 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002431545A Abandoned CA2431545A1 (fr) | 2001-01-05 | 2001-12-20 | Antagonistes du recepteur d'acide amine excitateur |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (fr) |
| JP (1) | JP2004520335A (fr) |
| KR (1) | KR20030066797A (fr) |
| CN (1) | CN1484642A (fr) |
| AR (1) | AR035679A1 (fr) |
| BR (1) | BR0116672A (fr) |
| CA (1) | CA2431545A1 (fr) |
| CZ (1) | CZ20031856A3 (fr) |
| DZ (1) | DZ3460A1 (fr) |
| EA (1) | EA200300770A1 (fr) |
| EC (1) | ECSP034682A (fr) |
| HR (1) | HRP20030544A2 (fr) |
| HU (1) | HUP0302528A2 (fr) |
| IL (1) | IL156138A0 (fr) |
| MX (1) | MXPA03005981A (fr) |
| NO (1) | NO20032973D0 (fr) |
| NZ (1) | NZ525821A (fr) |
| PE (1) | PE20020792A1 (fr) |
| PL (1) | PL361934A1 (fr) |
| SK (1) | SK8242003A3 (fr) |
| TW (1) | TW591023B (fr) |
| WO (1) | WO2002053561A1 (fr) |
| ZA (1) | ZA200304311B (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| JP2002505254A (ja) * | 1998-02-06 | 2002-02-19 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | パロキセチン塩 |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| TR200200066T2 (tr) * | 1999-07-06 | 2002-04-22 | Eli Lilly And Company | Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri |
-
2001
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Application Discontinuation
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/fr not_active Application Discontinuation
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/fr not_active Withdrawn
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/fr not_active Abandoned
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
-
2002
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
- 2003-07-03 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK8242003A3 (en) | 2004-01-08 |
| IL156138A0 (en) | 2003-12-23 |
| NO20032973L (no) | 2003-06-27 |
| AR035679A1 (es) | 2004-06-23 |
| BR0116672A (pt) | 2003-09-23 |
| EA200300770A1 (ru) | 2003-10-30 |
| HUP0302528A2 (hu) | 2003-11-28 |
| DZ3460A1 (fr) | 2002-07-11 |
| PL361934A1 (en) | 2004-10-18 |
| MXPA03005981A (es) | 2003-09-10 |
| ZA200304311B (en) | 2004-09-02 |
| NO20032973D0 (no) | 2003-06-27 |
| CZ20031856A3 (cs) | 2003-09-17 |
| CN1484642A (zh) | 2004-03-24 |
| WO2002053561A1 (fr) | 2002-07-11 |
| JP2004520335A (ja) | 2004-07-08 |
| NZ525821A (en) | 2004-07-30 |
| KR20030066797A (ko) | 2003-08-09 |
| ECSP034682A (es) | 2003-08-29 |
| TW591023B (en) | 2004-06-11 |
| EP1351955A1 (fr) | 2003-10-15 |
| HRP20030544A2 (en) | 2004-08-31 |
| PE20020792A1 (es) | 2002-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2378613C (fr) | Antagonistes selectifs du recepteur iglur5 utilises dans le traitement de la migraine | |
| US6579886B2 (en) | Selective iglur5 receptor antagonists | |
| EP1368032B1 (fr) | Antagonistes des recepteurs d'aminoacides excitatoires | |
| US6953805B2 (en) | Excitatory amino acid receptor antagonists | |
| US6855725B2 (en) | Excitatory amino acid receptor antagonists | |
| CA2431545A1 (fr) | Antagonistes du recepteur d'acide amine excitateur | |
| US20040082606A1 (en) | Excitatory amino acid receptor antagonists | |
| US6924294B2 (en) | Excitatory amino acid receptor antagonists | |
| AU2002227021A1 (en) | Excitatory amino acid receptor antagonists | |
| EP1351689A2 (fr) | Antagonistes des recepteurs d'aminoacides excitatoires | |
| US7205313B2 (en) | Excitatory amino acid receptor antagonists | |
| JP2004522804A5 (fr) | ||
| AU2001298028A1 (en) | Excitatory Amino Acid Receptor Antagonists | |
| JP2004520335A5 (fr) | ||
| ZA200109747B (en) | Selective iGluR5 receptor antagonists for the treatment of migraine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |